💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$4.2T
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 1/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $963.35B | $1072.43 | 2.89% |
| JNJ | Johnson & Johnson | $497.42B | $206.46 | 0.53% |
| ABBV | AbbVie Inc. | $402.40B | $227.70 | 0.02% |
| MRK | Merck & Co., Inc. | $263.46B | $104.83 | 0.19% |
| TMO | Thermo Fisher Scientific Inc. | $223.93B | $590.83 | 0.41% |
| AMGN | Amgen Inc. | $186.02B | $345.46 | 0.26% |
| GILD | Gilead Sciences, Inc. | $156.13B | $125.84 | 1.31% |
| PFE | Pfizer Inc. | $146.55B | $25.77 | 0.25% |
| VRTX | Vertex Pharmaceuticals Incorporated | $111.27B | $433.61 | 0.33% |
| MCK | McKesson Corporation | $110.14B | $881.12 | 0.29% |
| CVS | CVS Health Corporation | $102.01B | $80.36 | 0.63% |
| BMY | Bristol-Myers Squibb Company | $100.16B | $49.20 | 0.10% |
| REGN | Regeneron Pharmaceuticals, Inc. | $80.58B | $780.19 | 0.56% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $59.61B | $451.23 | 1.37% |
| ZTS | Zoetis Inc. | $56.53B | $128.28 | 0.46% |
| CAH | Cardinal Health, Inc. | $50.43B | $212.26 | 0.41% |
| INSM | Insmed Incorporated | $44.31B | $207.77 | 1.59% |
| VEEV | Veeva Systems Inc. | $39.50B | $240.29 | 0.16% |
| BIIB | Biogen Inc. | $26.71B | $182.09 | 0.08% |
| STE | STERIS plc | $26.20B | $266.28 | 0.21% |
| UTHR | United Therapeutics Corporation | $21.71B | $486.00 | 0.50% |
| INCY | Incyte Corporation | $20.51B | $104.46 | 1.13% |
| WST | West Pharmaceutical Services, Inc. | $19.95B | $277.25 | 0.04% |
| MEDP | Medpace Holdings, Inc. | $16.69B | $592.46 | 2.33% |
| NBIX | Neurocrine Biosciences, Inc. | $15.13B | $152.16 | 0.38% |
| RVMD | Revolution Medicines, Inc. | $15.03B | $77.76 | 0.23% |
| BBIO | BridgeBio Pharma, Inc. | $13.72B | $72.01 | 0.40% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $13.24B | $596.98 | 0.67% |
| IONS | Ionis Pharmaceuticals, Inc. | $13.15B | $82.73 | 0.04% |
| VTRS | Viatris Inc. | $12.32B | $10.70 | 0.52% |
| EXEL | Exelixis, Inc. | $11.84B | $44.17 | 0.09% |
| ELAN | Elanco Animal Health Incorporated | $11.56B | $23.27 | 0.17% |
| BMRN | BioMarin Pharmaceutical Inc. | $10.74B | $55.91 | 0.69% |
| WBA | Walgreens Boots Alliance, Inc. | $10.37B | $11.98 | 0.50% |
| MRNA | Moderna, Inc. | $10.15B | $25.98 | 3.88% |
| BAX | Baxter International Inc. | $9.63B | $18.74 | 0.85% |
| RGEN | Repligen Corporation | $9.63B | $171.02 | 0.09% |
| RNA | Avidity Biosciences, Inc. | $9.41B | $71.70 | 0.20% |
| HIMS | Hims & Hers Health, Inc. | $8.74B | $39.85 | 3.78% |
| HALO | Halozyme Therapeutics, Inc. | $8.40B | $71.40 | 1.73% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| CORT | Corcept Therapeutics Incorporated | $8.35B | $79.40 | 0.50% |
| CYTK | Cytokinetics, Incorporated | $8.11B | $68.13 | 0.03% |
| NUVL | Nuvalent, Inc. | $7.95B | $109.35 | 0.27% |
| AXSM | Axsome Therapeutics, Inc. | $7.64B | $151.50 | 0.34% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $7.29B | $52.70 | 8.68% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.28B | $109.09 | 1.55% |
| PTCT | PTC Therapeutics, Inc. | $6.90B | $85.99 | 0.30% |
| PCVX | Vaxcyte, Inc. | $6.49B | $49.61 | 0.08% |
| KRYS | Krystal Biotech, Inc. | $6.32B | $218.00 | 0.32% |
| GKOS | Glaukos Corporation | $6.10B | $106.29 | 0.85% |
| COGT | Cogent Biosciences, Inc. | $5.73B | $40.22 | 0.42% |
| PTGX | Protagonist Therapeutics, Inc. | $5.63B | $90.00 | 0.08% |
| TGTX | TG Therapeutics, Inc. | $5.28B | $33.26 | 0.45% |
| OPCH | Option Care Health, Inc. | $5.12B | $31.08 | 0.19% |
| KYMR | Kymera Therapeutics, Inc. | $4.88B | $67.88 | 0.03% |
| WGS | GeneDx Holdings Corp. | $4.83B | $166.95 | 0.81% |
| BLTE | Belite Bio, Inc | $4.80B | $137.44 | 6.03% |
| ADMA | ADMA Biologics, Inc. | $4.56B | $19.16 | 0.13% |
| SRRK | Scholar Rock Holding Corporation | $4.49B | $44.06 | 2.11% |
| AKRO | Akero Therapeutics, Inc. | $4.47B | $54.36 | 0.02% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $4.32B | $45.56 | 1.02% |
| ACAD | ACADIA Pharmaceuticals Inc. | $4.24B | $25.04 | 0.93% |
| IMVT | Immunovant, Inc. | $4.23B | $24.15 | 1.90% |
| INDV | Indivior PLC | $4.20B | $33.60 | 0.36% |
| VKTX | Viking Therapeutics, Inc. | $4.16B | $36.81 | 1.49% |
| PRAX | Praxis Precision Medicines, Inc. | $4.15B | $196.46 | 4.20% |
| ACLX | Arcellx, Inc. | $4.03B | $72.71 | 0.74% |
| LNTH | Lantheus Holdings, Inc. | $4.03B | $58.87 | 0.20% |
| LGND | Ligand Pharmaceuticals Incorporated | $4.00B | $203.18 | 1.45% |
| APGE | Apogee Therapeutics, Inc. | $3.95B | $71.97 | 2.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $3.94B | $12.52 | 0.00% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.75B | $30.65 | 1.00% |
| VCYT | Veracyte, Inc. | $3.74B | $47.34 | 0.78% |
| ICUI | ICU Medical, Inc. | $3.66B | $148.44 | 0.47% |
| MIRM | Mirum Pharmaceuticals, Inc. | $3.61B | $73.05 | 0.11% |
| SWTX | SpringWorks Therapeutics, Inc. | $3.54B | $46.99 | 0.02% |
| IRON | Disc Medicine, Inc. | $3.52B | $93.36 | 0.42% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.39B | $79.96 | 0.67% |
| CGON | CG Oncology, Inc. Common stock | $3.36B | $44.84 | 0.00% |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.35B | $34.75 | 2.93% |
| TVTX | Travere Therapeutics, Inc. | $3.17B | $35.41 | 2.34% |
| DYN | Dyne Therapeutics, Inc. | $3.13B | $21.90 | 3.45% |
| IDYA | IDEAYA Biosciences, Inc. | $3.12B | $35.62 | 0.72% |
| FOLD | Amicus Therapeutics, Inc. | $3.06B | $9.93 | 0.90% |
| PBH | Prestige Consumer Healthcare Inc. | $2.94B | $59.55 | 0.05% |
| CPRX | Catalyst Pharmaceuticals, Inc. | $2.88B | $23.41 | 0.09% |
| MLYS | Mineralys Therapeutics, Inc. | $2.86B | $43.12 | 0.55% |
| DNLI | Denali Therapeutics Inc. | $2.86B | $19.47 | 0.36% |
| RCUS | Arcus Biosciences, Inc. | $2.82B | $26.10 | 2.11% |
| LQDA | Liquidia Corporation | $2.79B | $32.63 | 2.87% |
| NUVB | Nuvation Bio Inc. | $2.75B | $8.04 | 0.37% |
| SLNO | Soleno Therapeutics, Inc. | $2.71B | $50.45 | 1.82% |
| APLS | Apellis Pharmaceuticals, Inc. | $2.69B | $21.30 | 1.34% |
| VRDN | Viridian Therapeutics, Inc. | $2.59B | $31.95 | 0.74% |
| BEAM | Beam Therapeutics Inc. | $2.57B | $25.33 | 1.20% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.55B | $45.59 | 1.45% |
| LEGN | Legend Biotech Corporation | $2.55B | $27.71 | 0.76% |
| TERN | Terns Pharmaceuticals, Inc. | $2.53B | $28.11 | 2.23% |
| WRBY | Warby Parker Inc. | $2.42B | $19.81 | 0.76% |